Author Archives: Steve Walker

First FDA-approved gene-therapy procedure for inherited blindness performed in US. Advance is fantastic news, but same quandary: Who can afford it?

The News: Massachusetts Eye and Ear, a Harvard teaching hospital based in Boston, recently became the first institution to treat a patient’s inherited retinal disorder with gene therapy. The patient,… Read more »

Insys attempting “Phoenix” impersonation as key Q1 earnings slated for Tuesday. Analysts say Buy, but is now the time?

The News: A former Insys Therapeutics Inc. (Chandler AZ) sales representative was recently sentenced to six months of home confinement after admitting that she participated in a scheme to pay… Read more »

Biotech IPO tsunami continues even as stocks sag following FDA chief’s drug-price rant.

The News: US Food and Drug Administration chief Scott Gottlieb on Thursday (May 3, 2018) questioned whether rebates that drugmakers provide to health insurers should remain protected by federal law,… Read more »

Boomer Alert: Aging immune cells increase risk for macular degeneration, blindness. Apellis, Ophthotech to the rescue?

The News: As people age, so do their immune systems. And new research at Washington University School of Medicine in St. Louis suggests that aging immune cells increase the risk… Read more »

Innovent Biologics epitomizes how China, not Russia, quickly becoming real threat to US biotech supremacy.

The News: China’s Innovent Biologics Inc. has raised $150 million in a Series E crossover round, with Capital Group Private Markets picking up $90 million of the mega-round, according to Endpoints. The… Read more »

Apitope moves Graves’ disease candidate toward Phase 2; a primer on autoimmune disease “for people in a hurry.”

The News: Apitope International NV has taken a step closer to developing the first new treatment option in decades for thyroid disorder Graves’ disease after posting positive results in a… Read more »

Elizabeth Holmes and Mark Zuckerberg: The rise and fall of the black turtleneck, hoodie and jeans. Op Ed

While scanning the healthcare news yesterday I was struck, perhaps a bit startled even, by a video clip of Facebook CEO Mark Zuckerberg, clad in a dark suit and tie and… Read more »

Coffee drinkers stunned as new study suggests caffeine consumption worsens Alzheimer’s symptoms. Now what?

The News: Long-term consumption of caffeine would worsen the neuropsychiatric symptoms of people with Alzheimer’s disease, according to a study on mice, published in Frontiers in Pharmacology. So far, many studies… Read more »

Healthcare stocks roar back after slump, while biotech IPOs continue stampede into pipeline.

The News: Rising healthcare stocks and fading qualms over an escalating Syrian conflict had Wall St. optimistic to start the week. Stocks had ended lower on Friday (April 13, 2018)… Read more »